• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一组非酒精性脂肪性肝病非饮酒者的临床、生化及组织学相关性

Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease.

作者信息

Canbakan B, Senturk H, Tahan V, Hatemi I, Balci H, Toptas T, Sonsuz A, Velet M, Aydin S, Dirican A, Ozgulle S, Ozbay G

机构信息

Department of Gastroenterology, Cerrahpasa Medical Faculty of Istanbul University.

出版信息

Acta Gastroenterol Belg. 2007 Jul-Sep;70(3):277-84.

PMID:18074737
Abstract

The correlation between biochemistry, imaging-studies and histology is a matter of controversy in non-alcoholic fatty liver disease (NAFLD) and the major pathophysiology of non-alcoholic steatohepatitis (NASH) is still unknown. We aimed to perform a comparative analysis between clinical, biochemical and histological variables of NAFLD. One-hundred and five NAFLD patients (F/M: 51/54), were studied, all with no-alcohol intake. The groups were followed-up for six months. Necroinflammation and fibrosis were more severe in patients with diabetes (p = 0.002, and p = 0.0001, respectively). In comparing NAFL to NASH, plasma nitric-oxide and malondialdehyde levels were significantly higher (p = 0.05, for-both), and vitamin-E and-C levels were significantly lower in NASH (p = 0.002, and 0.001, respectively). The serum ferritin levels were higher in NASH patients (p = 0.016). While the ultrasonographic grade was significantly higher, the liver-spleen density gradient was significantly lower in NASH group (p = 0.017, and 0.005, respectively). Within a six month period, serum ALT levels dropped into the normal range in 23/76 (30.3%) patients and serum ALT in the 6th month correlated significantly with the severity of steatosis, inflammation and fibrosis in initial biopsy (p = 0.023, 0.035, 0.011, respectively). In conclusion, the probability of severe liver disease is higher in patients with elevated-ALT in NAFLD. Serum ferritin levels have some prognostic significance in liver damage and fibrosis. Overt diabetes is predictive of advanced fibrosis and inflammation. However impaired glucose-tolerance is not. The advice on diet and exercise for six months after diagnosis may be a good strategy in NAFLD. The patients with normal-ALT without hepatomegaly, morbid-obesity and diabetes seem to have a good prognosis, however some of these patients may still require liver biopsy.

摘要

在非酒精性脂肪性肝病(NAFLD)中,生物化学、影像学研究与组织学之间的相关性存在争议,且非酒精性脂肪性肝炎(NASH)的主要病理生理学仍不清楚。我们旨在对NAFLD的临床、生化和组织学变量进行比较分析。研究了105例NAFLD患者(男/女:51/54),所有患者均无酒精摄入。对这些组进行了为期6个月的随访。糖尿病患者的坏死性炎症和纤维化更严重(分别为p = 0.002和p = 0.0001)。在比较NAFL与NASH时,NASH患者的血浆一氧化氮和丙二醛水平显著更高(两者均为p = 0.05),而维生素E和C水平显著更低(分别为p = 0.002和0.001)。NASH患者的血清铁蛋白水平更高(p = 0.016)。虽然超声分级显著更高,但NASH组的肝脾密度梯度显著更低(分别为p = 0.017和0.005)。在6个月内,23/76(30.3%)的患者血清ALT水平降至正常范围,且第6个月时的血清ALT与初始活检时的脂肪变性、炎症和纤维化严重程度显著相关(分别为p = 0.023、0.035、0.011)。总之,NAFLD患者中ALT升高时发生严重肝病的可能性更高。血清铁蛋白水平在肝损伤和纤维化方面具有一定的预后意义。显性糖尿病可预测晚期纤维化和炎症。然而,糖耐量受损则不然。诊断后6个月的饮食和运动建议可能是NAFLD的一个良好策略。ALT正常、无肝肿大、病态肥胖和糖尿病的患者似乎预后良好,然而其中一些患者可能仍需要进行肝活检。

相似文献

1
Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease.一组非酒精性脂肪性肝病非饮酒者的临床、生化及组织学相关性
Acta Gastroenterol Belg. 2007 Jul-Sep;70(3):277-84.
2
[Clinical and histological features of non-alcoholic fatty liver disease].非酒精性脂肪性肝病的临床和组织学特征
Zhonghua Gan Zang Bing Za Zhi. 2009 Nov;17(11):812-6.
3
Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).丙氨酸氨基转移酶水平对非酒精性脂肪性肝病患者非酒精性脂肪性肝炎(NASH)和肝纤维化的预测价值。
Liver Int. 2013 Oct;33(9):1398-405. doi: 10.1111/liv.12226. Epub 2013 Jun 13.
4
Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.非酒精性脂肪性肝病——组织学评分系统:一项大型队列单中心评估研究。
APMIS. 2017 Nov;125(11):962-973. doi: 10.1111/apm.12742.
5
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.非酒精性脂肪性肝病患者转氨酶水平正常时发生严重肝病的风险:胰岛素抵抗和糖尿病的作用
Hepatology. 2008 Sep;48(3):792-8. doi: 10.1002/hep.22429.
6
[Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].[一组病态肥胖患者中非酒精性脂肪性肝炎(NASH)的形态学诊断与肝功能检查之间的关系]
Rev Invest Clin. 2005 Jul-Aug;57(4):505-12.
7
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.使用配对活检评估非酒精性脂肪性肝病从脂肪变性进展为纤维性脂肪性肝炎的证据:对预后和临床管理的影响。
J Hepatol. 2015 May;62(5):1148-55. doi: 10.1016/j.jhep.2014.11.034. Epub 2014 Dec 1.
8
Serum ferritin levels predict histological severity in patients with nonalcoholic fatty liver disease in India.血清铁蛋白水平可预测印度非酒精性脂肪性肝病患者的组织学严重程度。
Indian J Gastroenterol. 2015 May;34(3):200-8. doi: 10.1007/s12664-015-0572-5. Epub 2015 Jun 25.
9
Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.不同血清丙氨酸氨基转移酶水平的非酒精性脂肪性肝病患者的代谢和组织学特征。
Aliment Pharmacol Ther. 2009 Feb 15;29(4):387-96. doi: 10.1111/j.1365-2036.2008.03896.x. Epub 2008 Nov 17.
10
A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver.一项对随访活检的系统评价显示,非酒精性脂肪肝患者的疾病在进展。
J Hepatol. 2013 Sep;59(3):550-6. doi: 10.1016/j.jhep.2013.04.027. Epub 2013 May 9.

引用本文的文献

1
Frequency and risk factors of metabolic associated fatty liver disease among medical students in Egypt.埃及医科学生中代谢相关脂肪性肝病的发病率及危险因素
Sci Rep. 2025 Apr 18;15(1):13470. doi: 10.1038/s41598-025-95753-w.
2
The effect of hepatic steatosis on 18F-FDG uptake in PET-CT examinations of cancer Egyptian patients.肝脂肪变性对埃及癌症患者PET-CT检查中18F-FDG摄取的影响。
Eur J Hybrid Imaging. 2023 Oct 16;7(1):19. doi: 10.1186/s41824-023-00173-6.
3
Association between serum ferritin level and the various stages of non-alcoholic fatty liver disease: A systematic review.
血清铁蛋白水平与非酒精性脂肪性肝病各阶段之间的关联:一项系统评价。
Front Med (Lausanne). 2022 Aug 3;9:934989. doi: 10.3389/fmed.2022.934989. eCollection 2022.
4
Ferritin as a key risk factor for nonalcoholic fatty liver disease in children with obesity.铁蛋白作为肥胖儿童非酒精性脂肪性肝病的关键风险因素。
J Clin Lab Anal. 2021 Feb;35(2):e23602. doi: 10.1002/jcla.23602. Epub 2020 Nov 28.
5
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.非酒精性脂肪性肝病的无创评估:当前证据与实践
World J Gastroenterol. 2019 Mar 21;25(11):1307-1326. doi: 10.3748/wjg.v25.i11.1307.
6
Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis.血清铁蛋白与非酒精性脂肪性肝病的关系:一项荟萃分析。
Lipids Health Dis. 2017 Dec 2;16(1):228. doi: 10.1186/s12944-017-0613-4.
7
Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals.热量均衡饮食变化与高心血管代谢风险个体的非酒精性脂肪肝
Nutrients. 2017 Sep 26;9(10):1065. doi: 10.3390/nu9101065.
8
Association between Dietary Vitamin C Intake and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Middle-Aged and Older Adults.膳食维生素C摄入量与非酒精性脂肪性肝病的关联:一项针对中老年人的横断面研究。
PLoS One. 2016 Jan 29;11(1):e0147985. doi: 10.1371/journal.pone.0147985. eCollection 2016.
9
Melatonin: a potential intervention for hepatic steatosis.褪黑素:一种治疗肝脂肪变性的潜在干预措施。
Lipids Health Dis. 2015 Jul 22;14:75. doi: 10.1186/s12944-015-0081-7.
10
Does vitamin C deficiency promote fatty liver disease development?维生素C缺乏会促进脂肪肝疾病的发展吗?
Nutrients. 2014 Dec 1;6(12):5473-99. doi: 10.3390/nu6125473.